| |
| |
|
| Insider
Information: |
Tzianabos Arthur |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
200,917 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$3,520,671 |
|
|
|
Indirect Value
|
$1,060 |
|
|
| Total
Shares |
201,917 |
|
|
| Total
Value |
$3,521,731 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tempest Therapeutics, Inc |
TPST |
President and CSO |
2015-12-03 |
25,400 |
2015-12-03 |
1,000 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-26 |
15,000 |
2016-08-26 |
0 |
Premium* |
|
|
Q32 Bio Inc |
QTTB |
|
2024-01-09 |
128,778 |
2019-06-03 |
0 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
Director |
2022-11-30 |
0 |
|
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
|
2024-02-13 |
31,739 |
2020-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
|
– • – |
2024-02-13 |
4 |
OE |
$2.19 |
$69,508 |
D/D |
31,739 |
31,739 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
|
– • – |
2024-01-09 |
4 |
AS |
$0.57 |
$7,445 |
D/D |
(13,037) |
128,778 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
|
– • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,420 |
141,815 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
Director |
– • – |
2023-01-09 |
4 |
AS |
$1.39 |
$14,762 |
D/D |
(10,616) |
108,395 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
Director |
– • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,000 |
119,011 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,930) |
0 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2022-01-05 |
4 |
AS |
$3.78 |
$20,239 |
D/D |
(5,354) |
86,011 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,860 |
91,365 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2021-02-19 |
4 |
AS |
$60.67 |
$606,652 |
D/D |
(10,000) |
0 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2021-02-19 |
4 |
OE |
$2.19 |
$21,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2020-11-23 |
4 |
AS |
$45.08 |
$920,566 |
D/D |
(20,000) |
0 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2020-11-23 |
4 |
OE |
$2.19 |
$43,800 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • – |
2020-06-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,930 |
|
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2020-02-03 |
4 |
AS |
$16.16 |
$202,021 |
D/D |
(12,500) |
77,505 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2020-01-02 |
4 |
AS |
$20.50 |
$256,191 |
D/D |
(12,500) |
90,005 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-12-02 |
4 |
AS |
$16.25 |
$203,176 |
D/D |
(12,500) |
102,505 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-11-29 |
4 |
AS |
$16.04 |
$200,559 |
D/D |
(12,500) |
115,005 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-10-01 |
4 |
AS |
$17.39 |
$217,468 |
D/D |
(12,500) |
127,505 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-09-03 |
4 |
AS |
$18.75 |
$234,320 |
D/D |
(12,500) |
140,005 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-08-01 |
4 |
AS |
$17.37 |
$217,111 |
D/D |
(12,500) |
152,505 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-07-01 |
4 |
AS |
$18.98 |
$237,300 |
D/D |
(12,500) |
165,005 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
President & CEO |
• • – |
2019-06-03 |
4 |
AS |
$19.86 |
$248,263 |
D/D |
(12,500) |
177,505 |
0 |
- |
|
| BIND |
DNIB Upwind Inc |
Director |
– • – |
2016-08-26 |
4 |
OE |
$0.44 |
$6,600 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
President and CSO |
• – – |
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,400 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
President and CSO |
• – – |
2015-04-09 |
4 |
B |
$28.77 |
$6,473 |
D/D |
225 |
400 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
